Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1992-06-05
1994-03-08
Knode, Marian C.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
424 9462, A61K 3754
Patent
active
052925099
ABSTRACT:
A method for selectively and completely disinserting the ocular vitreous body, epiretinal membranes and/or fibrocellular membranes from the neural retina, ciliary epithelium and posterior lens surface of the mammalian eye as an adjunct to vitrectomy comprises administering to the eye an effective amount of a protease-free glycosaminoglycanase enzyme, such as chondroitinase ABC, adapted to disrupt and/or degrade chondroitin sulfate glycosaminoglycan/proteoglycan localized specifically to sites of vitreoretinal adhesion and thereby permit complete disinsertion of the vitreous body and/or epiretinal membranes.
REFERENCES:
patent: 4174389 (1979-11-01), Cope
patent: 4524065 (1985-06-01), Pinnell
patent: 4696816 (1987-09-01), Brown
Winkler et al. "Hyaluronidase and Retinal Function", Arch Ophthalmol, 103 (11), pp. 1743-1746, 1985.
Thomson, "Addition of hyaluronidase to lignocaine with adrenaline for retrobulbar anesthesia in the surgery of senile cataract", Am. J. Ophthalmol, 107, p. 99 (1989), Abstract.
Bethesda Eye Institute
Knode Marian C.
LandOfFree
Method for the disinsertion of vitreous body by an enzyme which does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the disinsertion of vitreous body by an enzyme which , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the disinsertion of vitreous body by an enzyme which will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-151551